Steven Hendrickson, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Greensboro, NCNPI 1467457283
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Intuitive Surgical at 59.4% of the total. Reporting peaked in 2021 at $13,954 and has fallen 69.6% since, to $4,237 in 2025.
Across 86 payments — averaging $321.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$16K
- AstraZeneca$9K
- Atricure, Inc.$502
- Astrazeneca UK Limited$465
- Abiomed$397
- Galvanize Therapeutics, Inc$242
- plus $632 from 11 others
What the payments were for
- Consulting fees$7,67328%
- Speaking & faculty fees$1,5005%
- Travel & lodging$2,65210%
- Food & beverage$2,78210%
- Education$13,00047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 35 | $16,412 |
| AstraZeneca | 9 | $8,957 |
| Atricure, Inc. | 17 | $502 |
| Astrazeneca UK Limited | 1 | $465 |
| Abiomed | 5 | $397 |
| Galvanize Therapeutics, Inc | 2 | $242 |
| Auris Health, Inc. | 1 | $120 |
| Johnson & Johnson | 2 | $114 |
| Edwards Lifesciences | 3 | $86 |
| On Target Laboratories, Inc | 1 | $78 |
| LSI Solutions Inc | 3 | $60 |
| TELA Bio, Inc. | 1 | $57 |
| Zimmer Biomet | 2 | $36 |
| Kerecis Limited | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Getinge USA Sales, LLC | 1 | $19 |
| Angiodynamics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$15,703
- TAGRISSO$6,632
- IMFINZI$2,325
- ALIYA SYSTEM$242
- MONARCH$120
How this compares
$27,607 in reported general payments places this provider in the 75th percentile of 132 thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina.
See all thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 53 | $389 |
| Prednisone | 20 | $180 |
| Metoprolol Succinate | 16 | $116 |
| Oxycodone Hcl | 24 | $105 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Greensboro
- Harrell LightfootGreensboro$18K
- Edward GerhardtGreensboro$15K
- Joseph RubelowskyRaleigh$2.2M
- Matthew HartwigDurham$406K
- Gregory SmaroffNew Bern$205K
- David HarpoleDurham$177K
- Carmelo MilanoLumberton$169K
- Walter ChitwoodGreenville$139K
- Michael MillChapel Hill$137K
- Eric SkipperCharlotte$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.